drugset / Trial / NCT00967356
AZD5985 Single Ascending Dose Study
RandomizedParallel-groupTriple-blindBasic science
Summary
The aims of this study are to assess the safety, tolerability and pharmacokinetics of single ascending oral doses of AZD5985 in healthy male subjects.
Timeline
- Start
- 2009-08
- Primary completion
- —
- Completion
- 2009-11
Outcome
Outcome not reported
Stopped: “Terminated (halted prematurely) due to tolerability issues.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5985 | Unknown | 40 mg | Oral |
Indications
No indication recorded.